Saturday 19 March 2011

Excellent Presentation on LDN and 'Toll Like' Receptors (TLR2 etc)

Dr Rachel Allen at the Birmingham LDN Conference 2010 -


1 comment:

  1. Low-dose naltrexone has been suggested as a treatment for multiple sclerosis, Crohn’s disease and fibromyalgia. However for many LDN is still seen as very controversial. The Patient Experience is running a research blog to find our your views on LDN and its value! Please drop round and tell your story!

    http://www.patient-experience.com/index.php/low-dose-naltrexone-a-research-blog-for-patients-and-caregivers/

    ReplyDelete